TCR: A Potential Drug and Biomarker Target in T Cell Biology (P23180)

Target Name: alpha-beta T Cell Receptor Complex (TCR)

NCBI ID: P23180

alpha-beta T Cell Receptor Complex (TCR)

Other Name(s): alpha-beta TCR complex | alpha-beta T-cell receptor complex | alpha-beta T-lymphocyte receptor complex | Exact alpha-beta T lymphocyte receptor complex

TCR: A Potential Drug and Biomarker Target in T Cell Biology

The Alpha-Beta T Cell Receptor Complex (TCR) is a protein that plays a crucial role in the immune system. It is a complex of two important proteins, alpha-T cells receptor (伪TcR) and beta-T cell receptor (尾TcR). Both of these proteins are involved in cell signaling and are essential for the development and activation of T cells.

TCR is a key regulator of T cell development and activation. It is involved in the process of T cell receptor editing, which allows for the diversity of T cell responses to different antigens. TCR also plays a role in regulating the expression of genes involved in cell signaling and inflammation.

One of the most promising applications of TCR is as a drug target. Many drugs work by modulating T cell function, and TCR is a potential target for these drugs. For example, drugs that block TCR signaling have been shown to be effective in treating a variety of autoimmune diseases, including rheumatoid arthritis, lupus, and multiple sclerosis.

In addition to its potential as a drug target, TCR is also a potential biomarker. Because it is involved in so many aspects of T cell development and function, changes in TCR levels or function can be indicative of disease. For example, studies have shown that TCR levels are often reduced in people with rheumatoid arthritis, and that these levels may be a useful biomarker for this disease.

Another promising application of TCR is its role in cancer immunotherapy. TCR has been shown to play a key role in the immune response to cancer, and it is possible that targeting TCR with drugs could be an effective way to stimulate an immune response against cancer cells.

Overall, the Alpha-Beta T Cell Receptor Complex (TCR) is a protein that has the potential to revolutionize our understanding of T cell biology and immunology. Its role in cell signaling and disease makes it an attractive target for drug development, and its potential as a biomarker makes it an important area of research. Further studies are needed to fully understand the full potential of TCR and its potential as a drug and biomarker.

Protein Name: Alpha-beta T Cell Receptor Complex (TCR)

The "alpha-beta T Cell Receptor Complex (TCR) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about alpha-beta T Cell Receptor Complex (TCR) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets